Doc, will you sign my medical. Fellow in Hematology/Medical Oncology General Internal Medicine Grand Rounds
|
|
- Olivia Leonard
- 5 years ago
- Views:
Transcription
1 Doc, will you sign my medical marijuana card? Daniel W. Bowles, MD Fellow in Hematology/Medical Oncology General Internal Medicine i Grand Rounds September 21, 2010
2 Disclosures Skeptical about marijuana before researching this topic I serve on the State of Colorado MMAC
3 Why this topic? How many times have you been asked? What do you think about medical marijuana? Will you sign my card? I know this guy
4 Questions Does it help with symptoms, esp. nausea, anorexia, or pain? Is it better than our other meds? Will it make my patient s illness worse? What s the legal l situation ti in Colorado?
5 Outline Basics Timeline in history Discuss its role in symptom control Review effects on specific diseases Examine legal issues in Colorado
6 Basics: The Plant Cannabis sativa Highly adaptable 3-5 month life cycle Grows 15 cm/day Germinates within 6 days Requires little water Grows almost anywhere
7 Routes of administration Marijuana: Dried portions of the plant, esp. leaves and flowers Hashish: Resin from female flowers. Smash: Liquid concentrate of cannabis oil extracted from resin with solvents (acetone, gas, etc.) Hemp: Stalks and fibers of the plant. Contains <1% THC of recreational plants
8 Physiology Δ9-tetrahydrocannabinol (THC) Over 60 other known cannabinoids (cannabidiol-cbd) CR1:CNS, GI tract 9THC 11-hydroxy-THC CR2: peripheral, immune cells GABA, histamine, dopamine, p prostaglandins, opioids
9 Physiology CNS Low-grade euphoria Loss of inhibition Sensory changes Concentration changes Memory loss
10 History Native to temperate zones of Central Asia. One of the first plants cultivated by humans. Earliest recorded appearance of hemp in Taiwan 10,000-3,000 BC. Medicinal properties recognized 3000 BC, became a mainstay of Chinese medicine. Psychoactive effects recognized by 600 BC. Referenced in Taoism, Buddhism, the Vedas, the,,, Bible, the Koran.
11 Early History in North America 1606: Cannabis sativa first planted in Nova Scotia 1700 s: Hemp a mainstay of early American agriculture 1800s: Cannabis use not explicitly frowned upon
12 Modern History in North America 1920 s Harry Ainslinger and the Federal Bureau of Narcotics Linked with crime, promiscuity, etc s s-1940s Marijuana Tax Act (1937) requires registration and taxes Dr. Woodward from the AMA opposes
13 Modern History in North America s 1960 McCarthy and harsh penalties Hippies/counter culture 1970 s-1980 s Research into marijuana Renewed interest in medical uses
14 Medical Cannabis in the US : Present in pharmacies as antibiotic and analgesic 1850: US pharmacopoeia states myriad uses Late 1880s: Trend towards synthetics drugs 1942: Removed from pharmacopoeia 1967: All forms illegal by 1967 (US ratified a UN resolution) 1970: Made a schedule I substance 1970s-1980 s: interest in cannabinoids as therapy
15 Synthetic Cannabinoids in Medicine i Nabilone (Cesamet ) approved in 1985, marketed in 2006 Dronabinol (Marinol, 9-THC) approved in 1986 Levonantradol Sativex (THC and CBD). Approved in Canada
16 Do cannabinoids effectively relieve symptoms?
17 Colorado statistics as of December 31, 2009 Reported Condition Number of Patients Percent of Patients Reporting Condition Reporting Condition** Cachexia 700 2% Cancer 908 2% Glaucoma 382 1% HIV/AIDS 296 1% Muscle Spasms 12,077 29% Seizures 764 2% Severe Pain 37,912 92% Severe Nausea 6,696 16%
18 Cachexia (2%) Will cannabinoids help my patients gain or Will cannabinoids help my patients gain or maintain weight?
19 469 patients Megestrol acetate t 800 mg/d, oral dronabinol 2.5 mg twice a day, or both Multicenter trial US trial JCO 2002; 20:
20 Fig 1. Megestrol acetate improved (1) appetite, (2) physician-reported weight, (3) patient-reported weight, and (4) FAACT QOL score (Fisher's exact test, PP <.001,.02,.04, and.009, respectively). The UNISCALE found no significant differences in QOL. Bars represent 95% confidence intervals. Jatoi, A. et al. J Clin Oncol; 20: Copyright American Society of Clinical Oncology
21 Only difference in AEs is impotence JCO 2002; 20:
22 243 patients Cannabis extract (2.5 mg THC/1mg CBD) vs. THC vs. placebo 6 week trial Performed in Switzerland and Germany
23 Fig 2. Changes in visual analog scale (VAS) scores from baseline for appetite in the intent-to-treat population Strasser, F. et al. J Clin Oncol; 24: Copyright American Society of Clinical Oncology
24 Fig 3. Changes in visual analog scale (VAS) scores from baseline for quality of life (QOL) in the intent-totreat population Strasser, F. et al. J Clin Oncol; 24: Copyright American Society of Clinical Oncology
25 JCO 2006; 24:
26 139 pts: dronabinol 2.5mg bid vs. placebo 38% vs. 8% improve appetite e (p=0.05) 05) NS lessn nausea, improved mood
27 Cachexia conclusions Cannabinoids do not improve anorexia or QOL in advanced cancer Megesterol acetate is more effective in alleviating cachexia in cancer Cannabinoids id may improve appetite in HIV/AIDS No clear data on medical marijuana
28 Nausea/vomiting (16%) Will cannabinoids help keep my patient from Will cannabinoids help keep my patient from feeling nauseated and vomiting?
29 Chemo-induced nausea/vomiting (CINV) First studies performed in the mid-1970 s Most compare synthetic cannabinoids and pre-1990 s anti-emetics One study of smoked marijuana: 78% positive response NEJM 1975;293: NY State J Med 1988;
30 198 reports whittled to 30 evaluable trials Efficacy data on 1366 patients Average trial size was 46 patients 83% of trials used a cross over design Nabilone (16), dronabinol (13), levonantradol l (1) All evaluated acute CINV BMJ 2001; 323: 1-8
31 Copyright 2001 BMJ Publishing Group Ltd. Tramer, M. R et al. BMJ 2001;323:16
32 Copyright 2001 BMJ Publishing Group Ltd. Tramer, M. R et al. BMJ 2001;323:16
33 BMJ 2001; 323: 1-8
34 Curr Med Res Opin 2007; 23: 533 Delayed CINV
35 CINV conclusions Cannabinoids are more effective than older anti-emetics (e.g. Compazine) Cannabinoids have more side effects than older anti-emetics Cannabinoids id have little role in chronic CINV Little data about smoked marijuana
36 Non-chemo N/V
37 Muscle spasms (29%) 36%-43% of patients with MS report use Neurology 2004;62: Multiple Sclerosis 2006;12: Lancet 2003;362:
38 CAMS trial 630 pts at 33 sites Oral cannabis extracts vs. 9THC vs. placebo Lancet 2003;362:
39 Sativex in MS No difference in Ashworth scores Approved in UK in 2010 Eur. J. Neurol. 2007;14:
40 Severe pain (92%) Will cannabinoids help relieve my patient s Will cannabinoids help relieve my patient s pain?
41 9 single-dose trials Cross-over designs, single dose studies Cannabinoids id as effective as codeine mg Adverse events were common Problems: does not address smoked products, chronic use, adjunctive use BMJ 2001; 323: 1-6
42 Acute pain Smoked marijuana results in modest dose dependent relief in normal subjects Oral extract without effect Anesthesiology. 2007;107: Anesthesiology. 2008;109:
43 Neuropathic pain CT-3 (11-THC-oic) better than placebo for neuropathic pain (JAMA, 2003) Dronabinol > placebo in MS-central pain cross- over trial (BMJ, 2003) Sativex >placebo in MS (Neurology, 2005) Smoked cannabis > placebo in HIV neuropathy (BMJ, 2007) Nabilone < dihydrocodeine in neuropathic pain (5% v. 19% relief) with more toxicity (BMJ, 2008) JAMA 2003;290:1757. BMJ. 2004;329:253. Neurol. 2005;65: Neurol 2007; 68: BMJ 2008;
44 Prospective observational trial Single center in Canada 112 patients J Support Oncol 2008; 6:
45 J Support Oncol 2008; 6:
46 J Support Oncol 2008; 6:
47 Sativex and chronic cancer pain Phase IIb double-blinded blinded RCT Opiates +/- self-titrated Sativex in 3 dose ranges Superior to placebo at low and moderate doses (p < 0.05) 05) Similar number of patients with AEs with low and moderate doses Phase III completed and being analyzed
48 Pain conclusions Cannabinoids have modest analgesic effects in the acute setting More effective than placebo for neuropathic pain in HIV and MS Cannabinoids id may decrease opiate needs and serve as complementary meds Role in chronic, non-neuropathic pain is unknown
49 Will cannabinoids make the illness worse?
50 Marijuana and cancer risk No clear increase in all cancer risk No clear association with lung cancer No clear association with head and neck cancers Increased concern for fungal infections Cancer Causes Control 1997;8:722. Lancet Oncol 2005;6:35. Cancer Epidemiol 1999:8:1071. Cancer Prev Res 2009;2:759. Arch Intern Med. 2006;166:
51 Marijuana hyperemesis Chronic, heavy marijuana a use Improves with cessation of MJ Confused with chronic vomiting syndrome
52 Marijuana and other diseases Lung disease: Dose-dependant decrease in lung fucntion Schizophrenia: earlier presentation, worse psychosis Hepatitis C: increased steatosis t Thorax. 2007;62: Am J Psychiatry. 2010;167: Gastroenterology. 2008;134:432-9.
53 What s the status of medical marijuana in Colorado?
54 Physician Attitudes 1991, 54% of H/O MDs favored prescription MJ 2005 survey 994/2227 responses 36.1% agree with legalization, li 26% neutral, 37.8% opposed Internists t more likely l to approve than addiction med, psychiatry, or family medicine JCO 1991;9: J. Addict. Dis. 2005;24:87-93
55 NEJM 2010; 362: 1453
56 NEJM 2010; 362: 1453
57 Federal status Schedule I drug: no currently acceptable medical use 2005: Gonzales v. Raich confirmed that federal law enforcement can make arrests despite state laws October 2009: Department of Justice says federal resources should not be used to prosecute those in compliance with state laws NEJM 2010; 362: 1453
58 Legal Marijuana in Colorado 2000: Voters pass amendment 20 to legalize medical marijuana 2 oz. and 6 plants Patient and caregiver free from prosecution Dispensaries not established Summer 2009: Board of Health liberalized caregiver definition iti commercial dispensaries NEJM 2010; 362:
59 Green Rush : 2008: 2000 medical marijuana cards approved 2009: At least 43,000(!) approved by 12/09 August 2009: 270 applications/day February 2010: 1000 applications/day At least 230 dispensaries in Denver
60 Getting a card Can be prescribed by any licensed physician in Colorado $90 application fee
61 Colorado registry demographics 74% male Average age is 40 years >1000 different physician i prescribers Reported Condition Number of Patients Reporting Condition Percent of Patients Reporting Condition** Cachexia 700 2% Cancer 908 2% Glaucoma 382 1% HIV/AIDS 296 1% Muscle Spasms 12,077 29% Seizures 764 2% Severe Pain 37,912 92% Severe Nausea 6,696 16% Accessed 9/14/10.
62 Slow your roll House Bill 1284 and Senate Bill 109 passed in 2010 Dispensaries must have state and local licenses Dispensaries grow 70% of what they sell Cannot stay open past 7PM May be eligible for taxation Physicians need a bona fide relationship. Can report violations to CBME Accessed 9/14/10.
63 Medical marijuana in Colorado conclusions Use is growing rapidly Regulations changing rapidly Probably bl safe to prescribe
64 Conclusions Modestly effective in pain and in acute CINV Not effective in cancer-related cachexia Better than placebo in pain control Little data about symptom control with smoked marijuana
65 Medical cannabis conclusions Marijuana is not strongly correlated with cancer development Cannabinoids may have a role in cancer treatment Colorado is on the forefront f of dynamic medical marijuana issue
66
Medical Cannabis MATT WEBSTER DO, MS
Medical Cannabis MATT WEBSTER DO, MS Cannabis Sativa One of the oldest used drugs and medicinal remedies Most commonly abused illicit drug in the US There has been increasing access for medicinal MJ use
More informationMedical Marijuana Martin P. Eason MD, JD Associate Chief of Staff for Education Mountain Home VA Medical Center. Disclosure.
Medical Marijuana Martin P. Eason MD, JD Associate Chief of Staff for Education Mountain Home VA Medical Center Controversies in Pain Management Conference Johnson City, TN November 13, 2015 Disclosure
More informationCANNABIS FOR THE RHEUMATOLOGIST
CANNABIS FOR THE RHEUMATOLOGIST Dr Jagtar Singh Nijjar NIHR Clinical Lecturer in Rheumatology Disclosures None 1 Overview The history of cannabis use Anecdotal use of cannabis in chronic pain The biology
More informationThe Sale of Cannabis in Pharmacies. Michael H. Ghobrial, PharmD, JD Associate Director, Health Policy American Pharmacists Association
The Sale of Cannabis in Pharmacies Michael H. Ghobrial, PharmD, JD Associate Director, Health Policy American Pharmacists Association Development This activity was developed by the American Pharmacists
More informationFederal Law: Marijuana
Federal Law: Marijuana Marijuana is a Schedule I drug under Federal Controlled Substances Act Makes possession, usage, purchase, sale, and/or cultivation of marijuana illegal at the federal level May not
More informationCurious about Cannabis? Navigating the cannabis landscape in Pennsylvania LINDSEY MESTON, PHARMD ASHLEY FIRM, PHARMD
Curious about Cannabis? Navigating the cannabis landscape in Pennsylvania LINDSEY MESTON, PHARMD ASHLEY FIRM, PHARMD Speaker Disclosures We have/had no financial relationships with any commercial interests
More informationThe Shifting Federal Regulation of Cannabis Products
The Durham Bar 2019 CLE Program The Shifting Federal Regulation of Cannabis Products Erica M. Jackson, FDA Partner K&L Gates February 6, 2019 Copyright 2018 by K&L Gates LLP. All rights reserved. OVERVIEW
More informationHistory of Medical Cannabis in Nursing
History of Medical Cannabis in Nursing Kristen Luttenberger RN, MSN, CCRN, APNc http://marijuanapolitics.com/wp-content/uploads/2016/07/caduceus-lg.jpg https://images-na.ssl-imagesamazon.com/images/i/41gtt5pb4el._sx314_bo1,204,203,200_.jpg
More informationMedical Marijuana. Navigating Medical Marijuana in Workers Compensation
Medical Marijuana Navigating Medical Marijuana in Workers Compensation Agenda Federal and State Laws Public Health Adverse Effects & Concerns Clinical Use Implications for Employers Implications for Workers
More informationDr. G. Michael (Michael) Allan EDMONTON AB Dr. Christina (Tina) S. Korownyk EDMONTON AB MEDICAL CANNABANOIDS IN PRIMARY CARE
Society of Rural Physicians of Canada 26TH ANNUAL RURAL AND REMOTE MEDICINE COURSE ST. JOHN'S NEWFOUNDLAND AND LABRADOR APRIL 12-14, 2018 262 Dr. G. Michael (Michael) Allan EDMONTON AB Dr. Christina (Tina)
More informationResearch on Cannabis and PD: Is there any evidence?
Research on Cannabis and PD: Is there any evidence? Benzi M. Kluger, MD, MS Associate Professor of Neurology and Psychiatry Director Movement Disorders Center University of Colorado Denver DISCLOSURES
More informationMedicinal cannabis. What is medicinal cannabis? What are cannabinoids? The endocannabinoid system
Medicinal cannabis What is medicinal cannabis? Broadly speaking, medicinal cannabis is cannabis prescribed to relieve the symptoms of a medical condition, such as epilepsy. It is important to make the
More informationMEDICAL CANNABIS IN MINNESOTA
MEDICAL CANNABIS IN MINNESOTA MINNESOTA ACADEMY OF PHYSICIAN ASSISTANTS MARCH 18, 2016 TOM ARNESON, MD, MPH MDH OFFICE OF MEDICAL CANNABIS 2014: Minnesota becomes 22 nd state with a medical cannabis program
More informationMedical Marijuana. Speaker Disclosure Requirements. Share with a Partner 4/10/2015
Medical Marijuana Kent W. Peterson, MD, FACOEM Occupational Health Strategies, Inc. Charlottesville, VA Speaker Disclosure Requirements 1. Do not dispense, prescribe, refer or recommend MMJ 2. Have no
More informationMedical Marihuana for Patients in the Lymphoma Setting. Speakers: Ruth Turner, RN, Con Rob Laister, PhD
Medical Marihuana for Patients in the Lymphoma Setting Speakers: Ruth Turner, RN, Con Rob Laister, PhD Medical Marihuana for Patients in the Lymhoma Setting Disclosure: No endorsement or promotion of marihuana
More informationMarijuana and Adolescents: Truth and Consequences. Disclosure Statement OBJECTIVES. Secondary Objectives. State of Marijuana in US
Marijuana and Adolescents: Truth and Consequences Clinical Advances in Pediatrics Symposium Children s Mercy Park September 28, 2017 Disclosure Statement I have no actual or potential conflict of interest
More informationCOMIRB Protocol Number: PI: Madeline Cole, MS-III Michael Chan, MS-III Dan Matlock, MD MPH. Dear Fellow Medical Student,
COMIRB Protocol Number: 13-2387 PI: Madeline Cole, MS-III Michael Chan, MS-III Dan Matlock, MD MPH Dear Fellow Medical Student, We are conducting a study to assess the attitudes and experiences of medical
More informationCannabinoids: access and symptom management in cancer
Cannabinoids: access and symptom management in cancer Appetite stimulation Anecdotal reports suggest marijuana stimulates appetite AIDS/HIV dronabinol 2.5 mg bd v placebo (n=88) increase in appetite 38%
More informationDoes Legality equal Legitimacy? The challenges of fostering safe practice with state legalization of marijuana
Does Legality equal Legitimacy? The challenges of fostering safe practice with state legalization of marijuana Carla Lomuscio, LCSW, Betsy Long, MSW and Amy Carver, PharmD Disclosures We have no financial
More informationOutcome. Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana. Connie J. Cerilli, APRN, FNP-C
Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana Connie J. Cerilli, APRN, FNP-C Outcome Participants will be able to list 3 approved medical conditions Participants will
More informationEducating Ohio Providers On The Basics Related To Recommending Medical Marijuana. Connie J. Cerilli, APRN, FNP-C
Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana Connie J. Cerilli, APRN, FNP-C Outcome Participants will be able to list 3 approved medical conditions Participants will
More informationThe Cannabis model in Canada and the USA. Dr Mark A Ware MD MRCP MSc McGill University Montreal, Quebec, Canada
The Cannabis model in Canada and the USA Dr Mark A Ware MD MRCP MSc McGill University Montreal, Quebec, Canada Outline Canada Cannabinoid medicines Existing regulatory framework Proposed new regulations
More informationMedical Marijuana: The Move to Schedule II
Medical Marijuana: The Move to Schedule II David Deitz, MD, PhD David Deitz & Associates Today s discussion Does medical marijuana actually treat anything? What are the workplace issues? What are the interactions
More informationJames Donaldson CEO and Executive Director
Welcome! James Donaldson CEO and Executive Director Dr. Natasha Ryz Chief Science Officer, Zenabis Cannabis 101 Introduction to Cannabis Plant Cannabis is a genus of flowering plants within the family
More informationIs there a role for medical marijuana in the management of IBD? Jami A. Kinnucan, MD Division of Gastroenterology University of Michigan Hospital
Is there a role for medical marijuana in the management of IBD? Jami A. Kinnucan, MD Division of Gastroenterology University of Michigan Hospital Disclosures No relevant financial or relationship disclosures
More informationRecent trends in medical cannabis use in Canada
Recent trends in medical cannabis use in Canada Paul Grootendorst Faculty of Pharmacy, University of Toronto Department of Economics, McMaster University Cannabis therapeutic effects Cannabis has been
More informationMedical Marijuana A Primer for Pharmacists
Medical Marijuana A Primer for Pharmacists Emory S. Martin, PharmD FASHP Texas Society of Health System Pharmacists Learning Objectives Recognize key components of the endocannabinoid system Identify possible
More informationMEDICAL CANNABIS IN MINNESOTA
MEDICAL CANNABIS IN MINNESOTA EPILEPSY & SEIZURES WELLNESS EXPO APRIL 16, 2016 MICHELLE LARSON, MPA MDH OFFICE OF MEDICAL CANNABIS 2014: Minnesota becomes 22 nd state with a medical cannabis program State
More informationMarijuana. DATE: February 21, 2017 PRESENTED BY: Melissa Weimer, DO, Assistant Professor of Medicine
Marijuana DATE: February 21, 2017 PRESENTED BY: Melissa Weimer, DO, Assistant Professor of Medicine Objectives Describe marijuana laws in the state of Oregon and the nation List evidence available for
More informationUnderstanding Maine s Medical Marijuana Law
Understanding Maine s Medical Marijuana Law Maine Pharmacy Association May 20, 2011 Background 1999: Maine Medical Marijuana Act passes as initiated bill (I.B.) Authorizes medical use of marijuana for
More informationUse of Cannabinoids in Medical Practice
Use of Cannabinoids in Medical Practice Annual Scientific Assembly Family Medicine Review 2016 Murray Opdahl BSPE, MD, CCFP Objectives Briefly present: An overview of available cannabinoids Concerns voiced
More informationMEDICAL MARIJUANA: WHAT S THE EVIDENCE?
MEDICAL MARIJUANA: WHAT S THE EVIDENCE? L A U R A A. M A R K L E Y, M D B O A R D - C E R T I F I E D I N P E D I A T R I C S / G E N E R A L P S Y C H I A T R Y / C H I L D & A D O L E S C E N T P S Y
More informationMedical Cannabis Program. Dr. Maureen Small Co Medical Director Andrea Sundberg Program Coordinator
Medical Cannabis Program Dr. Maureen Small Co Medical Director Andrea Sundberg Program Coordinator Disclaimer The following information is based upon research of current studies. The Department of Health
More informationJames McCormack BSc (Pharm), PharmD Professor Faculty of Pharmaceutical Sciences University of British Columbia Vancouver, BC, Canada
James McCormack BSc (Pharm), PharmD Professor Faculty of Pharmaceutical Sciences University of British Columbia Vancouver, BC, Canada My Agenda Discuss the best available evidence Put the evidence into
More informationResearch: Medical Cannabis
Research: Medical Cannabis Background The hemp plant Cannabis sativa (cannabis) is commonly known as marijuana and can be used as a therapy to alleviate symptoms such as pain and fatigue caused by chronic
More information9/28/2015. Support. R01CA A1 Intervening with smoking parents of inpatients to reduce
Medical marijuana and the impact of marijuana policy on children Karen M. Wilson, MD, MPH, FAAP Associate Professor of Pediatrics Section Head, Pediatric Hospital Medicine University of Colorado School
More informationCannabis and What we Know. Bonnie Schnittker RN PHN Public Health Nurse October 20, 2017
Cannabis and What we Know Bonnie Schnittker RN PHN Public Health Nurse October 20, 2017 We All Have a Role to Play! Objectives What is Cannabis? What do we know about the health effects? Legalization:
More informationOverview of Cannabis Laws
Overview of Cannabis Laws Morgan Leach Attorney at Law Jesse J. Richardson, Jr. Professor of Law Overview Legal classifications Historical overview Controlled Substances Ace and DEA Actions Recent federal
More informationUse of Medical Marijuana in Cancer Treatment & Care
Use of Medical Marijuana in Cancer Treatment & Care Ronald Stram,MD Stram Center for Integrative Medicine April 2016 Introduction Board Certified Medical Doctor, Integrative and Functional Medicine 28
More informationThe Return of Medicinal Cannabis
The Return of Medicinal Cannabis George Kolodner, M.D. DLFAPA FASAM Chief Clinical Officer Clinical Professor of Psychiatry Georgetown University School of Medicine University of Maryland School of Medicine
More informationTHE STATE OF THE STATES-A REPORT ON MEDICAL CANNABIS PROGRAMS MID YEAR MEETING AND SCIENTIFIC SEMINAR APRIL 13, 2018 NASHVILLE, TENNESSEE DEBBY MIRAN
THE STATE OF THE STATES-A REPORT ON MEDICAL CANNABIS PROGRAMS MID YEAR MEETING AND SCIENTIFIC SEMINAR APRIL 13, 2018 NASHVILLE, TENNESSEE DEBBY MIRAN LEARNING OBJECTIVES Participants will learn about each
More informationDecember 2018 Brief Explanation of Proposition 2 and Compromise Bill Passage
December 2018 Brief Explanation of Proposition 2 and Compromise Bill Passage You are probably already getting calls from patients about medical marijuana. You probably have many questions about how it
More informationMarijuana. DATE: June 26, 2018 PRESENTED BY: Melissa Weimer, DO, MCR, FASAM
Marijuana DATE: June 26, 2018 PRESENTED BY: Melissa Weimer, DO, MCR, FASAM Disclosures Speaker: Melissa Weimer, DO, MCR, has nothing to disclose. Planning Committee: The members of the planning committee
More informationMedical Marijuana Update Chris Belletieri, DO
Dr. Belletieri has provided no disclosures. Graduated PCOM in 1996 In private practice since 1999 Board Certified in FP since 1999 Program Director of FP residency at Lower Bucks Hospital in Bristol, PA
More informationMarijuana: Laws Allowing the Limited Use of Low-THC Oil for Medicinal Purposes
Marijuana: Laws Allowing the Limited Use of Low-THC Oil for Medicinal Purposes Research current through May 19, 2015. Revised June 5, 2015. This project was supported by Grant No. G1399ONDCP03A, awarded
More informationMedical vs Recreational Use of Cannabis. 11 th December 2017
1 Medical vs Recreational Use of Cannabis 11 th December 2017 2 Defining Cannabis and Chemical Constituents Cannabis is a plant species. Two main Cannabis sub-species are Cannabis Sativa and Cannabis Indica.
More informationLegalized Marijuana: Uses, Misuses & Abuses. Disclosures. Objectives. Kennon Heard University of Colorado SOM Dept Of Emergency Medicine
Legalized Marijuana: Uses, Misuses & Abuses Kennon Heard University of Colorado SOM Dept Of Emergency Medicine Disclosures Research grants McNeil Consumer Healthcare (Acetaminophen) Rare Disease Therapeutics
More informationThe Effects known & unknown of Marijuana in Older Adults. Danielle Fixen, PharmD, BCGP, BCPS University of Colorado School of Pharmacy
The Effects known & unknown of Marijuana in Older Adults Danielle Fixen, PharmD, BCGP, BCPS University of Colorado School of Pharmacy Learning Objectives 1. Review various dosing strategies for medical
More informationLearning Objectives 1/8/2019. Therapeutic Potential of the Marijuana-Derived Cannabinoids THC and CBD. Disclosures. Outline. Take home messages
Therapeutic Potential of the Marijuana-Derived Cannabinoids THC and CBD CECILIA HILLARD, PHD DEPARTMENT OF PHARMACOLOGY NEUROSCIENCE RESEARCH CENTER Disclosures Member of the Scientific Advisory Board
More informationA look at Marijuana in 2014
A look at Marijuana in 2014 Paul Snyder MA., LADC Overview and Objectives Discuss the mental and physical effects of marijuana use Describe the criteria for Cannabis use disorder according to the DSM 5
More informationMedical Cannabinoids for the Management of Chronic Noncancer Pain
Medical Cannabinoids for the Management of Chronic Noncancer Pain Dr Mark A. Ware MBBS MSc McGill University 12 June 2018 Disclosures Grants: CanniMed Consulting: CHI Inc Emmes 1 Canadian Consortium for
More informationMedicinal cannabinoids where does it fit in Palliative Care? Janet Hardy Phillip Good Georgie Cupples Matthew Spitzer
Medicinal cannabinoids where does it fit in Palliative Care? Janet Hardy Phillip Good Georgie Cupples Matthew Spitzer Medicinal cannabis Substantial public interest Legalised by the Qld Government Guidance
More informationOhio s Medical Marijuana Control Program
Ohio s Medical Marijuana Control Program Timeline September 8, 2016 House Bill 523 Effective November 5, 2016 Deadline for first Medical Marijuana Advisory Committee meeting May 6, 2017 Cultivator rules
More informationTHE COMPLETE CBD GUIDE
THE COMPLETE CBD GUIDE WHAT IS CBD (CANNABIDIOL)? 2 WHERE DOES CBD COME FROM? 3 HOW DOES CBD WORK IN THE BODY? 4 HOW MUCH CBD DO I TAKE? 5-6 CBD OIL VS. HEMP OIL 7 CBD NOT THC 8 THE BENEFITS OF CBD 9 PETS
More informationColorado s Cannabis Experience Doug Friednash
Colorado s Cannabis Experience Doug Friednash (dfriednash@bhfs.com) Brownstein Hyatt Farber Schreck, LLP Denver, Colorado 1 Marijuana in the US 62% of Americans say the use of marijuana should be legal.
More informationMedical Marijuana Consent Form
Medical Marijuana Consent Form A qualified physician may not delegate the responsibility of obtaining written informed consent to another person. The qualified patient or the patient s parent or legal
More informationChanging the Drug Enforcement Administration (DEA) Schedule of Tetrahydrocannabinol (THC), Cannabidiol and Combinations to Promote Research
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 TITLE: Changing the Drug Enforcement Administration (DEA) Schedule of Tetrahydrocannabinol
More informationMaine s Medical Marijuana Law. 40 th Annual ASMAC Fall Conference Ritz Carlton Lake Tahoe October 26, 2014
Maine s Medical Marijuana Law 40 th Annual ASMAC Fall Conference Ritz Carlton Lake Tahoe October 26, 2014 Medical Marijuana Laws Alaska (1998) Arizona (1996, 2010) California (1996) Colorado (2000) Delaware
More informationDiane E. Hoffmann, J.D., M.S. University of Maryland School of Law
Diane E. Hoffmann, J.D., M.S. University of Maryland School of Law States that have decriminalized medical marijuana Characteristics of State Laws Allow patients to use and possess (and in most states
More informationMedical Cannabis. Danial Schecter, MD, CCFP. Vocational Rehabilitation Association November 7th, Executive Director Cannabinoid Medical Clinic
Medical Cannabis Danial Schecter, MD, CCFP Executive Director Cannabinoid Medical Clinic Vocational Rehabilitation Association November 7th, 2014 Conflict of Interest This program has not received financial
More informationMARIJUANA: EXPLORING THE PUBLIC HEALTH APPROACH
MARIJUANA: EXPLORING THE PUBLIC HEALTH APPROACH CIPHI CONFERENCE OCTOBER 2 ND 2017 FAREEN KARACHIWALLA, MD MPH CCFP FRCPC ASSOCIATE MEDICAL OFFICER OF HEALTH KFL&A PUBLIC HEALTH DISCLAIMER This presentation
More informationAct 16 and Medical Cannabis in Pennsylvania
Act 16 and Medical Cannabis in Pennsylvania Charles V. Pollack, Jr., MA, MD, FACEP, FAAEM, FAHA, FESC, FCPP Associate Provost and Professor of Emergency Medicine Director, Institute of Emerging Health
More informationWHO Expert Committee on Drug Dependence Pre-Review: Cannabis plant and resin. Expert Peer Review 2
WHO Expert Committee on Drug Dependence Pre-Review: Cannabis plant and resin Expert Peer Review 2 1. Comments based on the review report a. Evidence on dependence and abuse potential Dependence potential:
More informationADVANCED CLINICAL CANNABINOID PROVIDER EXAM ACCP
ADVANCED CLINICAL CANNABINOID PROVIDER EXAM ACCP Page 1 1. In what year did the possession and transfer of cannabis for recreational use become illegal in the United States? A. 1937 B. 1941 C. 1933 2.
More informationSenator Mark B. Madsen proposes the following substitute bill:
LEGISLATIVE GENERAL COUNSEL 6 Approved for Filing: S.C. Johnston 6 6 03-03-15 4:49 PM 6 S.B. 259 2nd Sub. (Salmon) Senator Mark B. Madsen proposes the following substitute bill: 1 MEDICAL CANNABIS AMENDMENTS
More informationAssessing Delawarean Physicians Perspectives and Knowledge of Medical Marijuana Barret Michalec, PhD; Laura Rapp, PhD; Tanya Whittle, MA Center for
Assessing Delawarean Physicians Perspectives and Knowledge of Medical Marijuana Barret Michalec, PhD; Laura Rapp, PhD; Tanya Whittle, MA Center for Drug and Health Studies, University of Delaware Fall
More informationResearch paper: Legal treatment of the use of cannabis for medical purposes in the member states of the European Union
Parliament of Montenegro Parliamentary Institute Research Centre Research paper: Legal treatment of the use of cannabis for medical purposes in the member states of the European Union Podgorica, December
More information79th OREGON LEGISLATIVE ASSEMBLY Regular Session. Senate Bill 1015 SUMMARY
th OREGON LEGISLATIVE ASSEMBLY--0 Regular Session Sponsored by Senator FERRIOLI Senate Bill SUMMARY The following summary is not prepared by the sponsors of the measure and is not a part of the body thereof
More informationDoris C. Gundersen MD Medical Director Colorado Physician Health Program Colorado Association of Medical Staff Services Conference Estes Park,
Doris C. Gundersen MD Medical Director Colorado Physician Health Program Colorado Association of Medical Staff Services Conference Estes Park, Colorado May 17, 2014 NOTHING TO DISCLOSE Colorado Physician
More informationBudding Therapies: Medical Cannabis and its Uses
Budding Therapies: Medical Cannabis and its Uses MARIAH CADAVOS, PHARMD & VIVIAN NGUYEN, PHARMD PGY1 PHARMACY PRACTICE RESIDENTS FEBRUARY 10, 2019 1 Disclosures & Disclaimer Both presenters have nothing
More informationSENATE BILL No. 676 AMENDED IN SENATE APRIL 28, 2011 AMENDED IN SENATE MARCH 31, Introduced by Senator Leno.
AMENDED IN SENATE APRIL, 0 AMENDED IN SENATE MARCH, 0 SENATE BILL No. Introduced by Senator Leno February, 0 An act to add Division (commencing with Section 000) to the Food and Agricultural Code, and
More information9/13/2017. Marijuana and the Brain Matthew Wong, MD Assistant Professor, Department of Neurology, Epilepsy Section. Disclosures.
Marijuana and the Brain Matthew Wong, MD Assistant Professor, Department of Neurology, Epilepsy Section Disclosures Site principal investigator of studies of cannabidiol(epidiolex) in the treatment of
More informationVOLUME 21 NO. 1 JANUARY 2016 Medical Marijuana: Evaluating the Quality and Quantity of Evidence Available
Pharmacy Tech Topics VOLUME 21 NO. 1 JANUARY 2016 Medical Marijuana: Evaluating the Quality and Quantity of Evidence Available AUTHOR: PEER REVIEWERS: EDITOR: DESIGN EDITOR: Jennifer Phillips, PharmD,
More informationMarijuana Law. Selected Legal Issues. Brian N. Morrow, Esq.
Marijuana Law Selected Legal Issues Brian N. Morrow, Esq. Disclosures & Conflicts None Here in my personal capacity Overview Federal law and state law are inconsistent why? Colorado as a case study Differences
More informationMedical Marijuana. 1. is a plant species, variety known as hemp. 3. Tetrahydrocannabinol is an aromatic with low water solubility.
Medical Marijuana Questions from Part 1: 1. is a plant species, variety known as hemp. a. Cannabis sativa Linnaeus b. Cannabis sativa c. Cannabis indica d. Cannabis Lemark 2. The major psychoactive compound
More informationHR UP IN SMOKE: THE INTERSECTION BETWEEN MARIJUANA LEGALIZATION AND EMPLOYMENT LAW. Michigan Municipal League
Michigan Municipal League HR UP IN SMOKE: THE INTERSECTION BETWEEN MARIJUANA LEGALIZATION AND EMPLOYMENT LAW Michigan Association of Planning 2018 Annual Fall Convention Grand Rapids, MI September 20,
More informationClinical Policy Title: Botanical marijuana for medical use
Clinical Policy Title: Botanical marijuana for medical use Clinical Policy Number: 00.02.10 Effective Date: January 1, 2015 Initial Review Date: August 20, 2014 Most Recent Review Date: October 19, 2017
More informationReferences: [1] Mohomed Ben Amar Cannabinoids in medicine: a review of their therapeutic potential. Journal of Ethnopharmacology 105: 1-25.
TESTIMONY OF Paul Armentano BEFORE THE PENNSYLVANIA HOUSE OF REPRESENTATIVES COMMITTEE ON HEALTH AND HUMAN SERVICES ON HB 1393 COMPASSIONATE USE ACT OF 2009 Good morning, Chairmen Oliver and Baker, and
More informationMedical Marijuana: Coverage Considerations for the Buckeye State. ISCEBS & CSHRM Education Session April 20, 2018
Medical Marijuana: Coverage Considerations for the Buckeye State ISCEBS & CSHRM Education Session April 20, 2018 DISCLAIMER Speaker has no conflicts of interest to disclose Cubic is an independent analytics
More informationSECTION V: EMPLOYEES POLICY 5375 MEDICAL MARIJUANA, HEMP & CANNABIDIOL (CBD)
Regardless of a student, employee, parent or any individual s status as a medical marijuana license holder, marijuana is not allowed on the premises of the district or in any school vehicle or in any personal
More informationCommunity Meeting: Local Cannabis Policy in Oroville
Community Meeting: Local Cannabis Policy in Oroville May 24, 2018 Presented by: Neil Hall, Cannabis Lead Kyle Tankard, Consultant Agenda Welcome/Introduction Cannabis 101 Presentation Public Comment Period
More informationLife s brighter under the sun MEDICAL CANNABIS AND GROUP BENEFITS PLAN COVERAGE
Life s brighter under the sun MEDICAL CANNABIS AND GROUP BENEFITS PLAN COVERAGE With the legalization of recreational cannabis upon us in Canada, our conversation about cannabis use is changing. It s not
More information78th OREGON LEGISLATIVE ASSEMBLY Regular Session. Senate Bill 964 SUMMARY
Sponsored by Senators BURDICK, KRUSE th OREGON LEGISLATIVE ASSEMBLY-- Regular Session Senate Bill SUMMARY The following summary is not prepared by the sponsors of the measure and is not a part of the body
More informationMedical Marijuana: Hype versus Evidence
Medical Marijuana: Hype versus Evidence Monica Malec, MD The University of Chicago, Department of Medicine Section of Geriatrics and Palliative Medicine Objectives Understand the requirements for physician
More informationDepartment of Public Safety
Presented by: Lindsey Wells, Marijuana Program Administrator Department of Public Safety Vermont Marijuana Registry March 6, 2015 Vermont Law School South Royalton, VT Information Marijuana Registry Staff
More informationCOUNTY OF SAN LUIS OBISPO
Cannabis Study Session Study Session Topics Cannabis v. Marijuana v. Hemp Current Regulations Medicinal and Adult-Use Cannabis Regulation Safety Act Neighboring Jurisdictions County s Permanent Regulation
More informationThe Evidence. Alex Crawley, BSP, ACPR RxFiles Academic Detailing Program
The Evidence Alex Crawley, BSP, ACPR RxFiles Academic Detailing Program Disclosure I have no relationships with commercial entities I have no real or perceived conflicts of interest I am employed by the
More informationNavigating the Rapidly Changing World of Marijuana and the Workplace. January 16, 2018
Legal Update Navigating the Rapidly Changing World of Marijuana and the Workplace January 16, 2018 Within the last few years, 28 states and the District of Columbia have legalized marijuana in varying
More informationCBD and Your Health.
CBD and Your Health. Cannabidiol (CBD) is a molecule found in plant species such as agricultural (or industrial) hemp, and Echinacea. CBD is one of at least 489 distinct compounds within hemp: it is clear
More informationCDHA 2016 Fall Symposium. Speaker Handout Files. For registered attendees only
CDHA 2016 Fall Symposium Speaker Handout Files For registered attendees only Providing Care in a Marijuana Legal World Heather Rogers, BSDH heatherrdh@heatherrdh.com Objectives We will discuss some of
More informationPOLICY NUMBER: POL 153
Chapter: CLAIMS Subject: MEDICAL CANNABIS Effective Date: October 25, 2018 Last Update: October 25, 2018 PURPOSE STATEMENT The purpose of this policy is to explain how the Workers Compensation Board determines
More informationClinical Education Initiative MEDICAL MARIJUANA 101. Speaker: Patricia Reed, PharmD
Clinical Education Initiative Support@ceitraining.org MEDICAL MARIJUANA 101 Speaker: Patricia Reed, PharmD 8/2/2017 Medical Marijuana 101 [video transcript] 00:00:12 - So we'll get started. Disclosures
More informationBasic Level English Exam MARIJUANA
Basic Level English Exam MARIJUANA Sample 1 The use of marijuana has ancient and honorable roots. As early as 3000 B.C., the Chinese used it as a folk medicine and prescribed derivatives of Cannabis Sativa
More information8/31/2016. Workplace Implications of Marijuana in the US. Goal
Workplace Implications of Marijuana in the US Copyright 420 Medicated.com Goal Inform and provoke discussion about the future for patients, staff and employers in regard to this rapidly evolving and important
More information4/15/2019. US States with Marijuana Laws in Have ACOG and SMFM taken notice? THE EFFECTS OF MARIJUANA USE ON PREGNANCY AND LACTATION
THE EFFECTS OF MARIJUANA USE ON PREGNANCY AND LACTATION Susan R Davidson, MD Maternal Fetal Medicine Department of Ob/Gyn St. Mary s Hospital Madison, WI SSM Health I HAVE NO FINANCIAL DISCLOSURES TO REPORT
More informationApril 7, You have asked me to prepare an opinion letter regarding the legal status of cannabidiol ( CBD ).
Palmetto Synergistic Research, LLC d/b/a Palmetto Harmony Attn. Janel Ralph 216 Labonte Street, Unit B Conway, SC 29526 April 7, 2016 Re: Cannabidiol opinion letter Dear Ms. Ralph: You have asked me to
More informationCannabis Use: Scope of the Issue
Three Areas of Focus How Changing Cannabis Policy Will Affect Your Practice Kevin P. Hill, MD, MHS Director, McLean Hospital Division of Alcohol and Drug Abuse Belmont, MA Assistant Professor of Psychiatry,
More informationProposal 18-1: Marijuana Legalization
Proposal 18-1: Marijuana Legalization November 2018 Statewide Ballot Issues Webinar - October 16, 2018 Tim Michling, Research Associate Citizens Research Council of Michigan 2 Access our analyses, official
More informationWhat Cities Need to Know about the Arkansas Medical Marijuana Amendment ( AMMA ) 1
June 2017 1 2 What Cities Need to Know about the Arkansas Medical Marijuana Amendment ( AMMA ) 1 Mark R. Hayes, Director of Legal Services, and Lanny Richmond II, Staff Attorney Introduction In 2016, the
More informationHEALTH REFORM WATCH A Web Log of the Seton Hall University School of Law, Health Law & Policy Program RSS Feed Comments
HEALTH REFORM WATCH A Web Log of the Seton Hall University School of Law, Health Law & Policy Program RSS Feed Comments Editor in Chief Managing Editor Faculty Contributors Kathleen M. Boozang Nathan Cortez
More information